Holen Sie sich die Stockscreener-App
4.42
4.12%
-0.19
Handel nachbörslich:
4.50
0.08
+1.81%
Schlusskurs vom Vortag:
$4.61
Offen:
$4.65
24-Stunden-Volumen:
121.85K
Relative Volume:
0.01
Marktkapitalisierung:
$8.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.75M
KGV:
-1.36
EPS:
-3.25
Netto-Cashflow:
$-30.91M
1W Leistung:
-7.53%
1M Leistung:
-9.43%
6M Leistung:
+1,473%
1J Leistung:
+118.81%
1-Tages-Spanne:
$4.38
$4.68
1-Wochen-Bereich:
$4.38
$4.9586
52-Wochen-Spanne:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Firmenname
Cellectar Biosciences Inc
Sektor
Branche
Telefon
(608) 441-8120
Adresse
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Vergleichen Sie CLRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
4.42 | 12.69M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2020-07-01 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-21 | Fortgesetzt | ROTH Capital | Buy |
| 2019-09-13 | Eingeleitet | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
Published on: 2025-08-13 08:37:11 - Newser
What’s next for Cellectar Biosciences Inc. stock priceIndex Update & Long-Term Growth Plans - Newser
Cellectar Biosciences Inc. stock chart pattern explained2025 Market Overview & Long-Term Growth Portfolio Plans - Newser
Will Cellectar Biosciences Inc. see short term momentumJuly 2025 Short Interest & AI Powered Market Entry Strategies - Newser
How to recover losses in Cellectar Biosciences Inc. stockSummary of Trade Cycles in 5-Year Range - Newser
What moving averages say about Cellectar Biosciences Inc.Free Investment Strategy With Low Risk - Newser
Multi factor analysis applied to Cellectar Biosciences Inc.High Return Trade Roadmap with Setup Filters - Newser
How to manage a losing position in Cellectar Biosciences Inc.Free Weekly Potential Breakout Stock List - Newser
Cellectar Biosciences Inc. stock trend forecastTechnical Trend Forecast for Investors - Newser
What recovery options are there for Cellectar Biosciences Inc.Daily Stock Movement Forecast with Accuracy - Newser
A | What is Cellectar Biosciences, Inc.'s revenue forecastBest ROI Stock Strategies - newsyoung.net
Will a bounce in Cellectar Biosciences Inc. offer an exitPattern Recognition Tool for ROI Investors - Newser
Key metrics from Cellectar Biosciences Inc.’s quarterly dataFree Trade Ready Stock Watch for Short Term - Newser
Cellectar Biosciences reports Q2 financial results, conference call on August 14. - AInvest
Cellectar Biosciences to Unveil Q2 2025 Financial Results and Key Corporate Updates Next Week - Stock Titan
Ewing Sarcoma Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Nanovalent Pharma, Oncomatryx, Valent Technologies, Cellectar Biosciences, Eisai Inc - Barchart.com
Cellectar Biosciences Inc. Shows Early Signs of Technical StrengthInvestment Plan With Growth Optimization Finalized - metal.it
Is it the right time to buy Cellectar Biosciences Inc. stockInvest in stocks with long-term growth potential - Jammu Links News
When is Cellectar Biosciences Inc. stock expected to show significant growthGet real-time updates on market trends - Jammu Links News
Is Cellectar Biosciences Inc. stock overvalued or undervaluedExtraordinary market timing - Jammu Links News
What makes Cellectar Biosciences Inc. stock price move sharplyExceptional profit velocity - Jammu Links News
Published on: 2025-08-03 14:24:10 - Jammu Links News
How does Cellectar Biosciences Inc. generate profit in a changing economyRapid wealth creation - Jammu Links News
What are analysts’ price targets for Cellectar Biosciences Inc. in the next 12 monthsRecord-setting profit potential - Jammu Links News
Is Cellectar Biosciences Inc. a growth stock or a value stockMaximize returns with strategic stock selection - Jammu Links News
Should I hold or sell Cellectar Biosciences Inc. stock in 2025Invest smarter with daily trading signals - Jammu Links News
What are the latest earnings results for Cellectar Biosciences Inc.Get professional advice for portfolio optimization - Jammu Links News
Why Cellectar Biosciences Inc. stock attracts strong analyst attentionStable Growth Stock Overview Signal - beatles.ru
Oragenics' Stock Takes A Hit With New Offering Announcement - Finimize
What’s the recovery path for long term holders of Cellectar Biosciences Inc.Market Momentum and Signal Alerts Suggest Reversal - metal.it
Cellectar Biosciences Inc.’s Price Action Aligns with Quant SignalsFree Stock Market Practical Discussion Forums - beatles.ru
Cellectar Biosciences Inc. Could See a Relief Rally From SupportExit Ready Momentum Stock Watchlist Expanded - metal.it
Screener Results Flag Cellectar Biosciences Inc. as OversoldConsistent Gain Investment Strategies Emerge - metal.it
Published on: 2025-07-29 16:45:28 - metal.it
How high can Cellectar Biosciences Inc. stock goWeekly Setup Summary for Risk Controlled Trades - Newser
Why did Cellectar's operating expenses surge in Q4 2024? - AInvest
Published on: 2025-07-29 04:25:46 - Newser
Technical analysis overview for Cellectar Biosciences Inc. stockSwing Candidate List with Trade Cues - Newser
Cellectar Biosciences Inc. Builds Base for Possible ReboundFast Exit and Entry Strategy Guide Offered - metal.it
Why is Cellectar Biosciences Inc. stock attracting strong analyst attentionExpert Picks Outlook To Watch Now - Jammu Links News
How to manage a losing position in Cellectar Biosciences Inc. Predictive Screener for Daily Trade Watch - Newser
What is Cellectar Biosciences Inc. company’s growth strategyBuild your wealth with consistent stock growth - Jammu Links News
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cellectar Biosciences Inc-Aktie (CLRB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):